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Tobacco use remains the most significant modifiable cause of disability, death and illness
1
. In 
Portugal, 19,6% of the population aged ten years or more smoke
3
. A Cochrane review of 2008
7
 
concluded that a brief advice intervention (compared to usual care) can increase the likelihood of a 
smoker to quit and remain nonsmoker 12 months later by a further 1 to 3 %. Several studies have 
shown that Primary Care Physicians can play a key role in these interventions
8,9,10
. However we did 
not find studies about the effectiveness of brief interventions in routine consultations of Family 
Doctors in Portugal. For this reason we designed a Cohort Study to make an exploratory study about 
the effectiveness of brief interventions of less than three minutes in comparison with usual care in 
routine consultations. The study will be implemented in a Family Healthcare Unit in Beja, during six 
months. Family Doctors of the intervention group should be submitted for an educational and 
training program before the study begin. Quit smoking sustained rates will be estimated one year 
after the first intervention in each smoker. If, as we expect, quit smoking rates will be higher in the 
intervention group than in the control group, this may change Portuguese Family Doctors attitudes 





1.  THE STATE OF THE ART 
 
1.1. Burden of disease 
According to the World Health Organization (WHO) tobacco use remains the most significant 
modifiable cause of disability, death and illness, in particular cardiovascular and respiratory disease, 
in high income countries. Some key facts from the WHO Media Centre reveal that tobacco kills up to 
50% of its users and nearly six million people each year
1
. 
In Portugal, tobacco use has globally diminished along the last twenty years
2
. This reduction has been 
consistent in men while in women it is growing, particularly in youngest ages. Nearly twenty per cent 
of the Portuguese population aged ten years or more smokes
3 
and 8100 deaths in the year 2000 were 
attributed to smoking, most of them by cancer(3400) and cardiovascular diseases(1800)
4
. 
The delivery of timely and effective tobacco dependence interventions
 
can help to curb this highly 
significant health threat and reduce the disease burden and mortality of smokers
5,6
. 
Among smokers who are aware about the risks of tobacco use (e.g. public health messages, policy 
changes, cessation marketing messages, family members), nearly 60% to 70% want to quit smoking 
and the majority of these individuals have done at least an attempt to quit in any time of their 
lives
4,8,10
. A Cochrane review of 2008
7
 concluded that, assuming an unassisted quit rate of 2 to 3%, a 
brief advice intervention can increase the likelihood of a smoker to quit and remain nonsmoker 12 
months later by a further 1 to 3 %. 
 
1.2. What is the role of Primary Health Care?  




have shown that Primary Care Physicians or Family Doctors can play a key role 
in this strategy
9
 . Further studies 
10,11,12,13
 have also shown that smoking cessation interventions in 
Primary Health Care are simple, efficient and effective. In Portugal, the National Healthcare Service 
has a universal coverage of the population where the Family Doctors working in Healthcare Centers 
or Family Healthcare Units are the first point of care. This represents a mix of unique conditions 
which may increase the success of brief advice interventions aimed at increasing quit rates: 
- Multiple encounters face-to-face with tobacco users where brief interventions may fit, given time 
constraints of each encounter 
- Family Doctors have a deep knowledge of their patients, their family and social environment 
-  More than 70% of tobacco users visit their family doctor at least one time a year5, 10 







1.3. Which are the barriers to smoking cessation interventions in primary care? 
Many barriers have been identified against smoking cessation interventions in routine consultations 
by Family Doctors
12
. Time constraints for each consultation (about 15 minutes in Portugal) with many 
“competing” preventive interventions to address in the same visit
25
. Another barrier is an inadequate 
training
14,16







from the Cochrane Tobacco Addiction 
Review Group examined the evidence on training healthcare professionals to help people quit 
smoking. They found that training programs can influence attitudes and beliefs of physicians and 
warrant further attention to identify smokers and increase the number to who advice is offered and 
given support for quitting tobacco.  
In Portugal, the National Program for Prevention and Control of Tobacco Use aims that at least 50% 
of tobacco users with a consultation in the last 24 months have a brief intervention
19
. National 
guidelines include recommendations for the education and training of Healthcare Professionals in 
brief and intensive interventions for smoking cessation and the inclusion of clinical support systems in 
the usual medical electronic record software. 
 
1.4. Why is it important to do this study?  
Despite all the advantages cited above, smoking cessation interventions are not yet widely part of 
routine care 
12
 and various reasons are given for Family Doctors not providing smoking advice
15,17,18
 . 
Also, actual data of these interventions in routine consultations are unknown in Portugal. In the 
reviewed literature, no studies about the efficacy of a brief intervention in routine consultations of 




With this study we will pursue some of the aims of the National Program for Prevention and Control 
of Tobacco use (to educate and train healthcare professionals in smoking cessation interventions and 
to make a brief intervention in most of smokers) and at the same time we will evaluate the 




2. OBJECTIVES  
2.1. Primary Objective: 
To make an exploratory study to evaluate the effectiveness of brief interventions during 
routine consultations by Family Doctors in Portugal, compared to usual care. The 
effectiveness will be measured by the Relative Risk of sustained abstinence rate for at least 
one year after the first intervention. 
 
2.2. Secondary Objectives:  
1- To determine the effectiveness of training Family Doctors in brief interventions for smoking 
cessation. The effectiveness will be deducted from the results of the first objective. 
2- To explore the effectiveness of a brief intervention by Family Doctors in specific populations 
(e.g. pregnant women, teenagers, high cardiovascular risk patients, patients with diabetes 
mellitus, psychiatric patients and patients with chronic obstructive lung disease.).The decision 
to make a statistical analysis will depend on co-morbidities and number of patients in each 




3.1. Study Design: Cohort Study 
We have aimed to conduct a randomized trial to address this research question. However preliminary 
contacts with possible participants suggested that most physicians would decline to be randomized. 
Reasons to decline are basically the same found in other studies
12,15,17
: lack of time, difficulty to 
impress on smokers the importance of quitting, low perceived effectiveness of brief smoking 
cessation interventions and lack of training. We have thus decided for a cohort study design, 
controlling for confounders in the analysis. 
We plan to use this study as a feasibility study, allowing for the development of an educational 
package and to assess the use of resources that can later inform a cluster randomized trial. 
 
3.2. Setting: Primary Healthcare – Family Doctors Consultations at the USF AlfaBeja. 
The USF AlfaBeja it is a healthcare unit integrated in the Local Healthcare Unit of Baixo Alentejo (ULSBA), 
with nine Family Doctors working and delivering primary healthcare to 16277 individuals. The ULSBA, 
belonging to the National Healthcare Service, it is responsible for delivering primary and secondary 
healthcare services to all population in Baixo Alentejo, a region in the south of Portugal. 
 
3.3. Study population: All individuals between 15 and 84 years old (13451 individuals) who attended the 
Family Doctors belonging to the Family Healthcare Unit AlfaBeja (USF AlfaBeja). 
For ethical reasons, people suffering from terminal illnesses or those unwilling to participate will be 
excluded from the study. Also severe psychiatric disorders or addiction to other psychoactive substances 




 state that smokers over the age of 65 can benefit greatly from abstinence reducing 
their risk of death from coronary heart disease, Chronic Obstructive Lung Disease and lung cancer we did 
not find studies in very old people over the age of 84. We think that in this sub set of aged population the 
announced benefits of reduced mortality will not be significant enough to include them in the 
intervention group. That’s why we prefer to limit the study to individuals until 84 years of age. 
In July of 2012 the total prevalence of smokers between 15 and 84 years of age in the USF AlfaBeja was of 
10,7% ranging between Family Doctors from 4,5% to 18% (Table 1). This prevalence was obtained 









3.4. Description of the intervention: The intervention consists in the delivering of the recommendations 
of evidence-based guidelines
4,5,6,19
 according to the algorithm presented ahead.  
Although there is a wide variety in the definition of brief interventions (simple advice or minimal 
interventions), for the purpose of this study we define a brief intervention as a minimal counseling 
of less than 3 minutes, taking place during a consultation for any other motivation problem or 
complain
5
. The main purpose of this brief intervention is to identify tobacco users and to make a 
stepped intervention
6,8,18
 based on the transtheoretical model of behaviour change developed by 
Prochaska and DiClemente in 1982 and using the strategy of the five “A”
19
: Ask about tobacco use, 
Advise to Quit, Assess willingness to make a quit attempt, Assist in quit attempt and Arrange follow 
up. 
We have already asked all the nine Family Doctors of the USF AlfaBeja if they would like to participate 
in the study as intervention group and consequently in the training program. Only four of the nine 
Family Doctors accepted to participate as intervention group and to make a training program on the 
brief intervention protocol (Family Doctors A, B, D and I). These four Family Doctors will have a two 
days three hours course in which the importance and expected effectiveness of the intervention will 
be presented, as well as the protocol will be explained and trained some practical aspects with the 
use of pedagogic techniques such as role playing.(ANNEX I) . The other five Family Doctors (C,E,F,G 
and H) will be the control group and their patients who smoke will receive the usual care.  
 




Prevalence  (%) 
between 15-84 years 
A 255(16,6%) 
B 217(13,8%) 











The basic steps of the intervention are (see algorithm in page 12) : 
1) All patients within 15 to 84 years of age who have a consultation for any motive and for 
any Family Doctor of the USF AlfaBeja will be asked by the administrative support staff 
about tobacco consumption. If they are tobacco users a written informed 
consent(ANNEX II) will be provided for them by nurses to read and sign and a 
questionnaire about characteristics of tobacco consumption will be delivered to be 
completed while waiting for the consultation by Family Doctor (ANNEX III). 
2) The tobacco users from Family Doctors of the control group will receive usual care. The 
patient’s filled questionnaire will not be available for the Family Doctors of this control 
group. 
3) The Family Doctors of the intervention group will have access to the questionnaire filled 
by their patients and once the motivating problem of the consultation has been resolved, 
they will give a clear, strong and personalized advice to quit smoking and will assess 
about the willingness of the patient to make a quit attempt at this time. This brief 
intervention must be registered by the Family Doctor in a data collection sheet (ANNEX 
IV) 
4) If the tobacco user is not ready to quit, the family doctor will assure a follow-up contact 
or reassessment in the next consultation. If the tobacco user is willing or ready to quit 
assist the patient in quitting providing counseling and medication or referring him to a 
specialized consultation in the ULSBA. In any case arrange a follow-up contact either in 
person or via telephone and write all the information in the data collection sheet.  
5) If the tobacco user has already quitted and he or she is in the maintenance stage, a 
reinforcement advice should be done in every consultation and registered in the data 
collection sheet. 
3.5. Intervention period: This intervention will be applied for a period of six months. 
3.6. Outcomes assessment:  
1) Self reported abstinence via telephone one year after the first consultation for each smoker 
of the two groups (intervention and control) within the intervention period. 
The investigator will contact the smokers through one of telephone numbers registered in the 
patients’ questionnaire. The investigator will be unaware of smoker allocation during data 
collection. 





3.7. Data Collection: 
From the Patient´s questionnaire (ANNEX III): 
1) Socio-demographic characteristics (age, gender, educational level, family and 
cohabitation with smokers)  
2) Characteristics of individual’s tobacco consumption (daily consumption in number of 
cigarettes/day, age at the start, nicotine dependence measured by the Brief Fagerström 
test, motivation level measured by the Richmond test. 
From the physician’s data collection sheet (ANNEX IV) and clinical electronic records:  
3) Physician perception of the stage of behavior change according to the transtheoretical 
model of Prochaska and Diclemente, specifically the readiness and willingness to quit. 
4) Morbidity or specific status of the patient: pregnant woman, teenager, diabetics patients, 
high cardio-vascular risk patients, psychiatric patients and patients with chronic 
obstructive lung disease. 
5) Subsequent consultations in the intervention period of six months and possible 
alterations of the stage of behavior change. 
 
 
3.8. Potential confounders: 
1) Tobacco dependence, measured by a Brief Fagerström Test with three dependence levels: mild 
(0-2 points), moderate (3-4 points) and high(5-6 points). 
2) Motivation level measured by the Richmond Test with three levels: low motivation (0-6 points), 
moderate motivation (7-9 points), high motivation (10 points) 
3) Self-reported educational level, measured in an ordinal scale with five levels: uneducated, 
primary school, middle-school, high school, higher education. 

































Individuals 15 -84 years of age who consult a 
Family Doctor for any reason and answer with yes  
to the question: do you smoke? 
Exclusion criteria: 
- Severe psychiatric disorders 
-Terminal illnesses 
- Addiction to psychoactive substances  
 
Informed consent + Questionnaire 
Smokers who belong to Family 
Doctors C,E,F,G and H 
Smokers who belong to Family 
Doctors A,B,D and I 






KEEP ON SMOKING 






4. STATISTICAL ANALYSIS : 
  
 Quit Smoking Keep on 
smoking 




A B a+b a/a+b 
Usual Care C D c+d c/c+d 
 
1) Estimation of quit smoking rates in intervention and control groups. 
2) Estimation of Relative Risk (RR) of smokers to quit and maintain smoking cessation one year after 




3) Estimation of a crude odds ratio (OR) of smokers to quit and maintain smoking cessation one year 
after have been exposed to the brief intervention, in comparison with smokers of the control 
group (A*D/B*C) 
4) Using a logistic regression model, provide an estimate of OR adjusted for tobacco dependence, 
Richmond motivation level, self-reported education level and cohabitation with another smoker. 
 
RR 1 = Quit smoking rate with brief intervention 




5. ETHICAL ASPECTS: 
The study will respect the Helsinki’s Declaration and successive revisions as well as the norms 
of good clinical practice, specifically: 
1) Privacy and confidentiality of data will be assured by the investigator. 
2) Informed consent will be provided in verbal and written forms to participants of the two 
groups and all subjects will have opportunity to see in detail any item of the study or to 
give up in any moment. 
 
The protocol will be submitted for appreciation by the Ethical Committee of the ULSBA and 
by the National Data Protection Committee (CNPD) 
 
6. POTENTIAL BIAS:  
 
6.1. Follow up losses Bias: because of follow-up loss one year after the intervention period in both 
intervention and control groups. To prevent this bias at least two phone numbers are asked to the 
subject in the initial questionnaire. Also an “intention-to-treat” analysis will be used, analyzing all 
subjects according to the group which they were originally allocated. 
6.2. Selection Bias: The family doctors that accepted to be included in the intervention group are also 
those who have already the highest prevalence smoking rates, denoting more interest and sensibility 
for this problem.  
6.3. Performance Bias: it may occur differences in care provided by each family doctor in both 
groups. Education and training programs for family doctors before the study begins can be useful to 
reduce the occurrence of this kind of bias in the intervention group. 
6.4. Evaluation Bias: this can occur when evaluating by phone the smoking status of the subject one 





6.  TASKS AND TIMELINE 
7.1. PERMISSION TO IMPLEMENT THE STUDY 
When: July 2012 
How: Ask authorization of the USF AlfaBeja Coordinator to implement the study in his 
healthcare unit and explain to him the main objectives. Ask the Family Doctors of the USF 
AlfaBeja if they accept to participate as intervention group or control group. 
7.2. PREPARATION OF THE STUDY PROJECT DOSSIER  
When: September 2012 
How: Preparation of a dossier with the project, educational and training programs for 
healthcare professionals (family doctors, nurses and administrative support staff), 
questionnaires and informed consent form and data collection sheets. 
. 
7.3. SUBMISSION TO ETHIC COMMITTEE: 
When: October 2012 
How: presentation of the project dossier to the Ethic Committee of ULSBA for appreciation 
and approval. 
7.4. SUBMISSION TO THE NATIONAL DATA PROTECTION COMMITTEE: 
When: November 2012 
How: Submission for approval of the project dossier to the CNPD. 
7.5. PRESENTATION TO HEALTHCARE PROFESSIONALS OF USF ALFABEJA: 
When: December 2012  
How: One hour meeting with all healthcare professionals of the USF AlfaBeja with 
presentation of the project and definition of tasks for each professional class: administrative 
support staff, nurses and family doctors.  
7.6. EDUCATIONAL AND TRAINING PROGRAMS: 
When: From 15 December 2012 to 31 January 2013 
How: 1) Educational and training program of one hour/one day for support staff (how to ask 
with privacy if a patient smokes) 
16 
 
2) Educational and training program of two hours/one day for nurses ( how to present the 
informed consent form and the questionnaire to the patient and how to answer all possible 
questions the patient may ask).  
3) Educational and training program of three hours/two days for Family Doctors of the 
intervention group (ANNEX I) 
7.7. INTERVENTION PERIOD 
When: From 1 st February 2013 to 31 July 2013 
How: Weekly make sure all smokers involved have their informed consent forms signed. 
Verify if the patients questionnaires are completed, namely if there is at least two phone 
numbers registered. Follow-up of records and data collected by all healthcare professionals 
of the intervention group. Regular meetings and mailings to the healthcare professionals 
involved whenever it will be necessary and specially if there are protocol violations..  
7.8. FOLLOW-UP AND FINAL ASSESSMENT 
When: From February to July 2014 
How: Evaluation via telephone of tobacco use or smoking cessation of all subjects recruited 
during the intervention period in the two groups. This evaluation is with occultation whether 
the subject belongs to the intervention group or to the control group.   
7.9. DATA COLLECTION  
When: From February 2013 to September 2014 
How: Excel database of socio-demographic characteristics of each subject, characteristics of 
individual’s tobacco consumption, co-morbidities, physician perception of the stage of 
behavior change, type of brief intervention, subsequent consultations and final telephone 
evaluation. 
7.10. STATISTICAL ANALYSIS 
When: September and October 2014 
How: Estimation of quitting rates and relative risk  
7.11. STUDY CONCLUSION AND PUBLIC PRESENTATION 
When: From November 2014 to January 2015 
How: Discussion of results and investigator conclusions. Peer review and final manuscript. 
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